Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 7, 1998

View Archived Issues

Trinity Biotech Acquires Selfcare Line For US$4.5M

Gemini, Chiroscience Group Partner For Obesity Genes

Canada's NRC Joining Effort To Oversee Genomics Research

Challenge To Monsanto Quashed In High Court

Mutated-Gene Culprit That Causes Duncan Disease Located By Researchers

Elan Aiming At Oncology In $130M Deal With Ligand

Oxagen Enters Astra Deal For Atherosclerosis Genes

Oxford Biomedica Signs Pair Of Research Deals

UCL Spin-Out Inpharmatica Blends Computers, Genomics

Prolifix Ousts CEO Lewis After Less Than One Year

European Confusion Deepens In Controversy Over GMOs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.